Andreas Franke

Andreas Franke

Auto-generated profile, based on publicly available information

Andreas Franke

Power Management and Distribution Section, Power Systems, EMC & Space Environments Division, Electrical Department, European Space Agency, Noordwijk, The Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2019 in EP Europace
Verified
Journal Article
Open access
PDF file
EHEllen Hoffmann
Ellen Hoffmann
FSFlorian Straube
Florian Straube
KWKarl Wegscheider
Karl Wegscheider
MKMalte Kuniss
Malte Kuniss
DADietrich Andresen
Dietrich Andresen
SSS Schneider
S Schneider
To evaluate the effectiveness and safety of cryoballoon ablation (CBA) compared with radiofrequency ablation (RFA) for symptomatic paroxysmal or drug-refractory persistent atrial fibrillation (AF). Prospective cluster cohort study in experienced CBA and RFA centres. Primary endpoint was ‘atrial arrhythmia recurrence’, secondary endpoints were as follows: procedural results, safety, and clinical course. A total of 4189 patients were included: CBA 2329 (55.6%) and RFA 1860 (44.4%). Cryoballoon ablation population was younger, with fewer comorbidities. Procedure time was longer in the RFA group (P = 0.01). Radiation exposure was 2487 (CBA) and 1792 cGycm2 (RFA) (P < 0.001). Follow-up duration was 441 (CBA) and 511 days (RFA) (P < 0.0001). Primary endpoint occurred in 30.7% (CBA) and 39.4% patients (RFA) [adjusted hazard ratio (adjHR) 0.85, 95% confidence interval (CI) 0.70–1.04; P = 0.12). In paroxysmal AF, CBA resulted in a lower risk of recurrence (adjHR 0.80, 95% CI 0.64–0.99; P = 0.047). In persistent AF, the primary outcome was not different between groups. Major adverse cardiovascular and cerebrovascular event rates were 1.0% (CBA) and 2.8% (RFA) (adjHR 0.53, 95% CI 0.26–1.10; P = 0.088). Re-ablations (adjHR 0.46, 95% CI 0.34–0.61; P < 0.0001) and adverse events during follow-up (adjHR 0.64, 95% CI 0.48–0.88; P = 0.005) were less common after CBA. Higher rehospitalization rates with RFA were caused by re-ablations. The primary endpoint did not differ between CBA and RFA. Cryoballoon ablation was completed rapidly; the radiation exposure was greater. Rehospitalization due to re-ablations and adverse events during follow-up were observed significantly less frequently after CBA than after RFA. Subgroup analysis suggested a lower risk of recurrence after CBA in paroxysmal AF. ClinicalTrials.gov (NCT01360008), https://clinicaltrials.gov/ct2/show/NCT01360008.

17 October 2023 in IEEE Transactions on Aerospace and Electronic Systems
Verified
Journal Article
Open access
COCarlos Orts
Carlos Orts
Ausias GarrigosAusias Garrigos
Ausias Garrigos
DMDavid Marroqui
David Marroqui
AFAndreas Franke
Andreas Franke
This paper proposes a solar array regulation technique for a high-voltage satellite power bus. The regulation method combines on-off control at low frequency, i.e. kHz range, of highly efficient isolated and unregulated dc-dc converters operating at high frequency, i.e. hundreds of kHz. Although this technique can adopt different implementations, this paper deals with a hysteretic voltage control loop at low frequency, also known (Sequential Switching Shunt Regulator - S3R), and unregulated, isolated, current-fed, zero-voltage and zero-current push-pull dc-dc converters. Design guidelines and experimental validation are provided.